Filters
reset allOther countries
Results: 1 to 12 of 12
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
SPTBN2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
PreventionGenetics United States | 61 | 36 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Invitae United States | 638 | 419 |
|
Genomic UnityⓇ Comprehensive Ataxia Analysis (includes STR analysis of 16 loci) Variantyx, Inc. United States | 52 | 53 |
|
Fulgent Genetics United States | 505 | 132 |
|
Fulgent Genetics United States | 533 | 149 |
|
Ataxia, Comprehensive Evaluation Athena Diagnostics Inc United States | 44 | 42 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.